Statistics
Publications
15
Citations
839
H-Index
14
Active since
1985
Holly W. Smith is an author at Eli Lilly (United States) specializing in pharmacology, life sciences, and medicine.
Publications per year
1985–2015
15
15
LY2405319, an Engineered FGF21 Variant, Improves the Metabolic Status of Diabetic Monkeys
Andrew C. Adams, Carolyn A. Halstead, Barbara C. Hansen et al. · PLoS ONE · 2013 · 166 citations · Full text
Holly W. Smith, Anthony Butterfield, Deqin Sun · Regulatory Toxicology and Pharmacology · 2007 · 130 citations
Nonclinical Safety Biomarkers of Drug-induced Vascular Injury
Igor Mikaelian, Mark J. Cameron, Deidre A. Dalmas et al. · Toxicologic Pathology · 2014 · 46 citations
Pharmacy, Pharmacology, Toxicology +15
1–5 of 15